Health Trials

Her2-negative Locally Advanced Breast Cancer

1

Review clinical trials related to Her2-negative Locally Advanced Breast Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer

A Prospective, Multicenter, Randomized Controlled Phase II Study to Evaluate the Efficacy and Safety of Adebrelimab Combined with Chemotherapy with or without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer

Participants needed: 170
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Cancer Institute and Hospital, Chinese Academy of Medical SciencesUpdated: Jun 10, 2026Locations: 1
Eligibility criteria

Female patients aged between 18 and 70 years old. [+9]

Prior receipt of chest radiotherapy, chemotherapy, or immunotherapy. [+6]

Read more